A patient with vCJD who showed “remarkable” improvement after a controversial
drug treatment has died after reportedly suffering liver damage. Rachel Forber
was diagnosed with the human form of mad cow disease in June. Two months later
she began a course of chlorpromazine, an antipsychotic, and quinacrine, which is
normally used against malaria. Laboratory tests suggested that both drugs can
block the formation of prions, which cause vCJD. “It’s terrible for hope to be
given and then snatched away like that. We’re right back where we started with
no cure,” says Francis Hall of Britain’s Human BSE Foundation. But authorities…
To continue reading, today with our introductory offers
Advertisement
More from New Scientist
Explore the latest news, articles and features

Technology
'Green' cryptocurrency uses 18 times more energy than makers claim
News

ÎçÒ¹¸£Àû1000¼¯ºÏ
Your oral microbiome could affect your weight, liver and diabetes risk
News

Humans
Human heads have changed shape a lot in the past 100 years
News

ÎçÒ¹¸£Àû1000¼¯ºÏ
Doubts cast over 'wild' claim that magnetic control can turn on genes
News
Popular articles
Trending New Scientist articles
1
We have figured out a new way to send messages into the past
2
Human heads have changed shape a lot in the past 100 years
3
Thought-provoking photographs capture what it feels like to have ADHD
4
The best new science fiction books of May 2026
5
100-year-old assumption about the universe may soon be overturned
6
Ann Leckie continues to shine with new sci-fi novel Radiant Star
7
Largest-ever octopus was great white shark of invertebrate predators
8
Weird 'transdimensional' state of matter is neither 2D nor 3D
9
The rich but complicated legacy of genome pioneer Craig Venter
10
The bombshell results that demand a new theory of the universe